Clinical Trials · NCT03268811

A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302

CompletedPhase 3Teduglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Shire
Enrollment
9
Start date
Aug 2017
Locations
6 sites, Japan
Primary endpoint
Number of Participants With Treatment-emergent Adverse Events (TEAEs)
View Teduglutide compound reference